EXHIBIT 23.2
Published on
Exhibit
23.2
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We
consent to the incorporation by reference in the Registration Statement of
Rexahn Pharmaceuticals, Inc. on Form S-8 (Registration Statement No.
333-129294) and the Registration Statement of Rexahn Pharmaceuticals, Inc. on
Form S-3 (Registration Statement No. 333-152640) of our report dated March 24,
2008 (which report expresses an unqualified opinion), relating to the financial
statements of Rexahn Pharmaceuticals, Inc. included in this Annual Report on
Form 10-K of Rexahn Pharmaceuticals, Inc. for the year ended
December 31, 2008.
/s/ Lazar, Levine &
Felix LLP
New York,
New York
March 24,
2009